Prevest Denpro Peer Comparison

BSE: 543363

₹400.00

₹2.45 (0.62%)

As on 04-Nov-2026IST

Market cap

₹480 Cr

Revenue (TTM)

₹75 Cr

P/E Ratio

22.1

P/B Ratio

3.7

Div. Yield

0.3 %

Edit

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Market cap (₹ Cr)	480	534	52,105	16,093	7,211
Revenue (₹ Cr)	75	19	6,725	1,997	7,587
Net Profit (₹ Cr)	21.73	17.29	1,128.79	307.01	211.00
Net Margin (%)	27.10	47.19	16.02	14.56	2.75
RoE (%)	18.08	-2.13	11.51	10.63	10.44
Price to Earnings	22.10	--	46.16	51.07	34.17
Price-To-Book	3.68	0.65	4.90	5.06	3.49

Income Statement (₹ Cr)

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Operating Revenue	75.39	19.29	6,725.30	1,997.43	7,587.21
Total Income	80.54	36.64	7,045.33	2,108.80	7,666.42
Total Expenditure	48.49	18.24	4,974.15	1,536.06	6,956.12
EBITDA	26.89	1.05	1,751.15	461.36	631.09
Depreciation	2.02	0.12	433.87	128.17	310.44
EBIT	24.87	0.93	1,317.28	333.19	320.65
Interest	0.00	0.00	26.14	21.84	134.20
Other Income	5.16	17.35	320.03	111.37	79.21
Exceptional Items	0.00	0.00	-24.35	-6.80	0.00
Profit before Tax	30.03	18.28	1,586.82	415.92	265.65
Provision for Tax	7.46	0.99	458.02	108.91	54.66
Profit after Tax	22.57	17.29	1,128.79	307.01	211.00

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Shareholder's Funds	125.82	811.21	10,357.95	3,106.17	2,068.28
Minority Interest	0.00	0.00	0.00	2.16	0.04
Non-Current Liabilities	1.25	12.72	544.50	193.80	1,361.51
Current Liabilities	7.17	1.06	1,608.40	575.52	768.76
Total Liabilities	--	824.99	12,448.52	3,951.60	4,084.80

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Non-Current Assets	28.19	548.29	4,858.96	1,874.17	558.11
Current Assets	106.06	276.48	7,526.79	1,941.73	2,178.89
Total Assets	--	824.99	12,448.52	3,951.60	4,084.80
Total Debt*	--	0.00	243.36	341.62	0.00
Net Current Assets	98.89	275.42	5,918.38	1,366.21	1,410.13
Contingent Liabilities	--	2.90	10.12	50.21	14.06

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Cash From Operating Activities	--	2.05	1,031.39	246.37	495.58
Cash Flow from Investing Activities	--	-2.06	137.73	-225.38	-127.72
Cash from Financing Activities	--	--	-416.97	20.15	-255.51
Net Cash Inflow / Outflow	--	0.00	752.14	41.14	112.36

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
ROCE (%)	--	-9.33	14.96	14.05	22.22
ROE (%)	18.68	-2.13	11.51	10.63	10.44
ROA (%)	18.28	2.01	9.51	8.63	5.43
EBIT Margin (%)	33.00	4.82	19.59	16.68	4.23
Net Margin (%)	28.02	47.19	16.02	14.56	2.75
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Revenue Growth (%)	15.18	-5.21	17.57	18.31	20.57
EBIT Growth (%)	17.37	131.53	33.69	-9.66	11.48
Net Profit Growth (%)	17.65	-50.44	46.55	-12.67	8.18
EPS Growth (%)	17.65	-121.46	48.78	-10.52	7.89
Book Value Growth (%)	--	-7.21	12.70	12.14	14.76

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Price / Earnings	21.28	-30.38	45.40	50.27	34.13
Price / Book Value	3.65	0.65	4.90	5.06	3.49
Dividend Yield (%)	0.25	0.00	0.63	0.22	0.00
EV/EBITDA	14.82	249.17	27.98	33.83	10.69
Market Cap (₹ Cr)	--	511.04	27,964.97	12,069.92	10,057.49

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Debt to Equity	0.00	0.00	0.01	0.02	0.00
Short term debt to equity ratio	--	--	--	0.08	--
Current Ratio	14.79	260.83	4.68	3.37	2.83
Quick Ratio	13.29	259.03	3.60	2.62	0.86
Interest Coverage	--	0.00	61.70	20.04	2.98

	Prevest Denpro	Universus Imagings	Gland Pharma	Poly Medicure	Medplus Health
Debtors to sales (%)	11.66	1.81	28.12	26.59	0.51
Asset Turnover	0.61	0.02	0.57	0.56	1.95
Receivable days	--	15.02	96.72	85.20	1.05
Inventory Days	--	74.40	97.32	69.58	71.25
Payable days	--	13.26	134.60	77.97	21.75
Cash Conversion Cycle	--	76.16	59.43	76.82	50.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.